<DOC>
	<DOCNO>NCT01156025</DOCNO>
	<brief_summary>The study objective evaluate efficacy safety GV 550 comparison placebo patient acute adenoviral keratoconjuncivitis .</brief_summary>
	<brief_title>Efficacy Safety GV 550 Acute Adenovirus Keratoconjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<criteria>Written inform consent Male female age 18 80 year old Acute adenoviral keratoconjunctivitis Active ocular allergy Ocular herp√®s disease History bacterial conjunctivitis / blepharoconjunctivitis within last month inclusion visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>GV550</keyword>
	<keyword>Acute adenoviral keratoconjunctivitis</keyword>
</DOC>